Bioengineering Silicon Quantum Dot Theranostics using a Network Analysis of Metabolomic and Proteomic Data in Cardiac Ischemia

Abstract

Metabolomic profiling is ideally suited for the analysis of cardiac metabolism in healthy and diseased states. Here, we show that systematic discovery of biomarkers of ischemic preconditioning using metabolomics can be translated to potential nanotheranostics. Thirty-three patients underwent percutaneous coronary intervention (PCI) after myocardial infarction. Blood was sampled from catheters in the coronary sinus, aorta and femoral vein before coronary occlusion and 20 minutes after one minute of coronary occlusion. Plasma was analysed using GC-MS metabolomics and iTRAQ LC-MS/MS proteomics. Proteins and metabolites were mapped into the Metacore network database (GeneGo, MI, USA) to establish functional relevance. Expression of 13 proteins was significantly different (p<0.05) as a result of PCI. Included amongst these was CD44, a cell surface marker of reperfusion injury. Thirty-eight metabolites were identified using a targeted approach. Using PCA, 42% of their variance was accounted for by 21 metabolites. Multiple metabolic pathways and potential biomarkers of cardiac ischemia, reperfusion and preconditioning were identified. CD44, a marker of reperfusion injury, and myristic acid, a potential preconditioning agent, were incorporated into a nanotheranostic that may be useful for cardiovascular applications. Integrating biomarker discovery techniques into rationally designed nanoconstructs may lead to improvements in disease-specific diagnosis and treatment.

Cardiac Resynchronization Therapy Induces Adaptive Metabolic Transitions in the Metabolomic Profile of Heart Failure

“…Predictive analytics is emerging area in personalized medicine 56, 57 . This study suggests a specific plasma metabolic signature for response to CRT.…”

Proteomic analysis reveals ginsenoside Rb1 attenuates myocardial ischemia/reperfusion injury through inhibiting ROS production from mitochondrial complex I

“…It failed to alter O 2 consumption driven by substrates specific for complex II, further suggesting that its inhibition of RET-mediated ROS production was not due to the decrease in succinate accumulation and oxidation. Many omics technologies, such as proteomics and metabolomics, have been employed to identify potential therapeutic targets for ischemic heart diseases 42 , 43 . In the present study, proteomics results implied that ginsenoside Rb1 probably protected the heart from I/R injury by regulating complex I activity.…”

Emerging Trends in Nanocarbon‐Based Cardiovascular Applications

“…[150] However, due to the presence of heavy metals, M-QDs are largely associated with long-term toxicity and environmental concerns including aggregation that is regularly detected upon storage. [151] Also, the multistep complex process is required to obtain M-QDs. [152,153] The strong fluorescence imaging property in the NIR-II region can be used for labelling with organic dyes that can also serve as a T2-contrast agent for multimodal applications.…”